In early 2023, technology and pharmaceutical sectors focused heavily on advancing API capabilities, including expanded manufacturing for high-potency ingredients and the rapid adoption of AI-driven API solutions. Key developments included the launch of new HPAPI facilities to meet oncology demands and the standardization of software APIs for improved integration. For insights into the growth of API services, see the report at APi Group .